Exchange: NASDAQ·Updated 08:15 AM EDT
SHPH logo

SHPHShuttle Pharmaceuticals Holdings Inc

$4.95
$1.99
(67.23%)
Pre-Market
Prev Close $2.96
Reported EarningsMay 13
Mkt Cap$1.89M
Vol14.47M
News
all
press releases
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares rose 56.1% to $4.62 during Monday's after-market session. The company's market cap stands at $1.7 million. Medicus Pharma (NASDAQ:MDCX) stock rose 7.46% toread more...
Benzinga
News Placeholder
More News
News Placeholder
SHPH, ILLR, IVF: Why These Stocks Posted Double-Digit Gains After-Hours Today
AI infrastructure plan, SpaceX exposure, and Nasdaq compliance update boosted investor sentiment.
Stocktwits
News Placeholder
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 66.9% to $6.31 during Thursday's after-market session. The company's market cap stands at $2.1 million. INVO Fertility (NASDAQ:IVF) stockread more...
Benzinga
News Placeholder
Bitcoin Rises Toward $80,000 After Oil Drops On Iran Peace Signals – Triggers $200 Million Short Squeeze
Bitcoin’s price rose to an intraday high of nearly $80,000 as oil prices eased after reports of a potential Iran-U.S. peace deal.
Stocktwits
News Placeholder
Why Is SHPH Stock Soaring Today? Dogecoin Mining Pivot Sparks Rally
Shuttle Pharmaceutical Holdings signed a definitive merger agreement to acquire United Dogecoin and become a Dogecoin miner.
Stocktwits
News Placeholder
5 Biotech Stocks with Highly Anticipated Pending Results
Biotech M&A is heating up, making small-cap firms with breakthrough assets top acquisition targets and potential big winners for investors.
Stocktwits Contributor
News Placeholder
Shuttle Pharma Ramps Up Fight Against Glioblastoma With New Leadership, Promising Clinical Trial, and Bold Innovations
George Scorsis takes helm as Chairman as Ropidoxuridine trial nears 50% enrollment and patent advances boost pipeline.
Stocktwits Contributor
News Placeholder
Growth Stocks Are Beaten Down. Why It’s Temporary and What Should Be On Your Shopping List Instead
According to Goldman Sachs Research, a 5% increase in the tariff rate is estimated to reduce S&P 500 earnings per share by 1%-2%
Sponsored
News Placeholder
Here’s Why Shuttle Pharma is the Most Undervalued Biotech Stock in Our Coverage Universe
Stocktwits Contributor
News Placeholder
Shuttle Pharma (SHPH) Stock Surges on Clinical Trial, Financing and Debt Elimination News
Shares of Shuttle Pharmaceuticals are on the rise following a string of recent developments, including positive updates on its Phase 2 clinical trial, a new $4.5 million public offering and the paying off of a convertible note.
Stocktwits Contributor
<
1
2
...
>

Advertisement|Remove ads.